Virginia Wealth Management Group, Inc. Abb Vie Inc. Transaction History

Virginia Wealth Management Group, Inc.

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 03, 2023	BUY	$133.59 - $154.65 $1,870 - $2,165	14 Added 0.46%	3,058 $455,000
Q2 2023 Aug 08, 2023	BUY	$132.51 - $164.9 $1,855 - $2,308	14 Added 0.46%	3,044 $410,000
Q1 2023 May 05, 2023	BUY	$144.61 - $166.54 $2,747 - $3,164	19 Added 0.63%	3,030 $482,000
Q4 2022 Feb 07, 2023	BUY	$138.31 - $165.87 $1,798 - $2,156	13 Added 0.43%	3,011 $486,000
Q3 2022 Oct 19, 2022	SELL	$134.21 - $153.93 $145,349 - $166,706	-1,083 Reduced 26.54%	2,998 $402,000
Q2 2022 Aug 09, 2022	BUY	$137.62 - $174.96 $561,627 - $714,011	4,081 New	4,081 $625,000

3,785

1.28B

13M

9.82M

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $355B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

Get notified when there are updates to the investment portfolio of Virginia Wealth Management Group, Inc., based on Form 13F filings with the SEC.

Stay updated on Virginia Wealth Management Group, Inc. with notifications on news.